FrancophonIA/ELRC3.0 huggingface dataset:
English: • You could have mucosal inflammation as a swelling redness of the inside of the mouth leading to painful ulcers and mouth sores inflammation of the mouth (stomatitis), or as an inflammation of the gastrointestinal tract when Yondelis is used with PLD.
Slovenian: • Pri uporabi zdravila Yondelis skupaj s PLD se lahko v ustih pojavi vnetje sluznice ali oteklost s pordelostjo, kar povzroči boleče razjede in ustne rane (stomatitis), pojavi se lahko vnetje prebavil.
English: • Higher skin pigmentation could occur in patients receiving Yondelis with PLD for ovarian cancer.
Slovenian: • Pri bolnicah, ki prejemajo zdravilo Yondelis in PLD za raka na jajčnikih, se lahko pojavi večja pigmentacija kože.
English: Soft tissue sarcoma
Slovenian: Sarkom mehkega tkiva
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila Yondelis Vsebina pakiranja in dodatne informacije
English: A syringe is used to inject 20 ml of sterile water for injections into the vial.
Slovenian: Za injiciranje 20 ml sterilne vode za injekcije v vialo se uporabi injekcijska brizga.
English: Overall survival, n (%) Secondary endpoints n=345
Slovenian: Primarni opazovani dogodek n = 384 n = 193 Celokupno preživetje, n (%) Sekundarni opazovani dogodki n = 345 n = 173
English: Diluted solution After dilution, chemical and physical stability has been demonstrated for 30 hours up to 25ºC.
Slovenian: Po razredčitvi je kemična in fizikalna stabilnost dokazana za 30 ur pri temperaturi do 25 ºC.
English: Breast-feeding is contraindicated during treatment and 3 months thereafter (see section 4.3).
Slovenian: Med zdravljenjem in 3 mesece po njem je dojenje kontraindicirano (glejte poglavje 4.3).
English: A syringe is used to inject 5 ml of sterile water for injections into the vial.
Slovenian: Za injiciranje 5 ml sterilne vode za injekcije v vialo se uporabi injekcijska brizga.
English: The reconstituted solution should be diluted with sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion.
Slovenian: Rekonstituirano raztopino je treba redčiti z natrijevim kloridom 9 mg/ml (0,9 %) raztopino za infundiranje ali glukozo 50 mg/ml (5 %) raztopino za infundiranje.
English: If central venous access is not feasible and a peripheral venous line has to be used, the reconstituted solution should be added to an infusion bag containing ≥ 1,000 ml of diluent (sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion).
Slovenian: Če dostop preko centralne venske linije ni možen in je treba uporabiti periferno vensko linijo, je treba rekonstituirano raztopino dodati v vrečko za infundiranje, ki vsebuje ≥ 1.000 ml topila (natrijev klorid 9 mg/ml (0,9 %) raztopina za infundiranje ali glukoza 50 mg/ml (5 %) raztopina za infundiranje).
English: The geometric mean dose normalized trabectedin exposure (AUC) increased by 97% (90% CI: 20%, 222%) in 6 patients with moderate hepatic impairment (increased serum bilirubin levels from 1.5 to 3 x ULN and increase of aminotransferases (AST or ALT) < 8 x ULN) following administration of a single trabectedin dose of 0.58 mg/m2 (n=3) or 0.9 mg/m2 (n=3) compared to 9 patients with normal liver function following administration of a single trabectedin dose of 1.3 mg/m2 (see sections 4.2 and 4.4).
Slovenian: povečala za 97 % (90 % CI: 20 %, 222 %) v primerjavi z devetimi bolniki z normalnim delovanjem jeter, ki jim je bil apliciran enkraten odmerek trabektedina 1,3 mg/m2 (glejte poglavji 4.2 in 4.4).
English: Efficacy analyses from ET743-OVA-301 Yondelis+PLD
Slovenian: Rezultati učinkovitosti iz študije ET743-SAR-3007
English: You should have received training on the correct techniques to reconstitute and dilute Yondelis or its combination with PLD and you should wear protective clothing including mask, goggles and gloves during the reconstitution and dilution.
Slovenian: Naučiti vas morajo pravilnih tehnik rekonstituiranja in redčenja zdravila Yondelis ali njegove kombinacije s PLD.
English: Common: may affect up to 1 in 10 people
Slovenian: Pogosti: pojavijo se pri do 1 od 10 bolnikov
English: In this case you may experience fever, difficulty in breathing, redness or flushing of the skin or a rash, feeling sick (nausea) or being sick (vomiting).
Slovenian: težave z dihanjem, rdečico ali vročinske oblive ali izpuščaj, občutek slabosti (navzea) ali bruhanje.
English: Pyrexia
Slovenian: ciklov.
English: Thrombocytopenia:
Slovenian: Hiperbilirubinemija:
English: - if you are allergic to trabectedin or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na (preobčutljivi za) trabektedin ali katerokoli sestavino zdravila Yondelis,
English: Very common: may affect more than 1 in 10 people
Slovenian: Drugi manj resni neželeni učinki: Zelo pogosti: pojavijo se lahko pri več kot 1 od 10 bolnikov
English: One ml of reconstituted solution contains 0.05 mg of trabectedin.
Slovenian: En ml rekonstituirane raztopine vsebuje 0,05 mg trabektedina.
English: Potassium hydroxide (for pH-adjustment)
Slovenian: 6.1 Seznam pomožnih snovi saharoza kalijev dihidrogenfosfat fosforna kislina (za prilagoditev pH) kalijev hidroksid (za prilagoditev pH)
English: Dilute the reconstituted solution with sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion.
Slovenian: Navodila za redčenje Rekonstituirano raztopino razredčite z natrijevim kloridom 9 mg/ml (0,9 %) raztopino za infundiranje ali glukozo 50 mg/ml (5 %) raztopino za infundiranje.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Yondelis 0.25 mg powder for concentrate for solution for infusion Trabectedin
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Yondelis 0,25 mg prašek za koncentrat za raztopino za infundiranje trabektedin i.v.
English: 12 months PFS rate (95% CI) (%) Independent oncology review, all randomised n=336
Slovenian: Neodvisna onkološka ocena, vse randomizirano n = 336
English: Placental transfer of trabectedin and fetal exposure to trabectedin were observed in a study in pregnant rats that received a single i.v.
Slovenian: V študiji na brejih podganah, ki so prejele enkraten i.v.
English: If administration is to be made through a central venous line, the appropriate amount of reconstituted solution should be withdrawn from the vial and added to an infusion bag containing ≥ 50 ml of diluent (sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion), the concentration of trabectedin in the infusion solution being ≤ 0.030 mg/ml.
Slovenian: Če bo potekalo dajanje prek centralne venske linije, potegnite iz viale ustrezno količino rekonstituirane raztopine in jo dodajte v infuzijsko vrečko, ki vsebuje ≥ 50 ml topila (natrijev klorid 9 mg/ml (0,9 %) raztopina za infundiranje ali glukoza 50 mg/ml (5 %) raztopina za infundiranje), pri čemer je koncentracija trabektedina v raztopini za infundiranje ≤ 0,030 mg/ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Yondelis 1 mg powder for concentrate for solution for infusion Trabectedin
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Yondelis 1 mg prašek za koncentrat za raztopino za infundiranje trabektedin i.v.
English: If intravenous administration is to be made via a central venous line, add the reconstituted solution to an infusion bag containing ≥ 50 ml of diluent (sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion), the concentration of trabectedin in the infusion solution being ≤ 0.030 mg/ml.
Slovenian: Če bo intravensko dajanje potekalo prek centralne venske linije, dodajte rekonstituirano raztopino v infuzijsko vrečko, ki vsebuje ≥ 50 ml topila (natrijev klorid 9 mg/ml (0,9 %) raztopina za infundiranje ali glukoza 50 mg/ml (5 %) raztopina za infundiranje), pri čemer je koncentracija trabektedina v raztopini za infundiranje ≤ 0,030 mg/ml.
English: Serious side effects caused by the treatment with Yondelis:
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Yondelis:
English: Yondelis must not be given to patients who are breast-feeding.
Slovenian: Zdravila Yondelis se ne sme dajati bolnikom z izhodiščnim številom nevtrofilcev manj kot
English: Extravasation should be managed by local standard practice.
Slovenian: Posebnega antidota za ekstravazacijo trabektedina ni. Ekstravazacijo je treba obravnavati v skladu z uveljavljeno lokalno prakso.
English: Febrile neutropenia
Slovenian: Pri hudi nevtropeniji
English: Mucosal inflammation
Slovenian: Razredčena raztopina
English: NAME OF THE MEDICINAL PRODUCT Yondelis 0.25 mg powder for concentrate for solution for infusion Trabectedin
Slovenian: Yondelis 0,25 mg prašek za koncentrat za raztopino za infundiranje trabektedin
English: A syringe is used to inject the correct amount of sterile water for injections into the vial.
Slovenian: Za injiciranje sterilne vode za injekcije v vialo se uporabi injekcijska brizga.
English: Yondelis 1 mg powder for concentrate for solution for infusion.
Slovenian: Yondelis 1 mg prašek za koncentrat za raztopino za infundiranje trabektedin
English: Yondelis contains potassium
Slovenian: Yondelis+PLD
English: Respiratory, Thoracic and Mediastinal Disorders
Slovenian: Bolezni jeter, žolčnika in žolčevodov
English: Talk to your doctor before using Yondelis
Slovenian: Pred začetkom uporabe zdravila Yondelis se posvetujte z zdravnikom.
English: You could experience general swelling or swelling of the limbs and a sensation of creeping on the skin.
Slovenian: Možno je, da boste dobili splošne otekline ali otekline okončin in kurjo polt.
English: Trabectedin crossed the placenta when administered to pregnant rats.
Slovenian: Ko so trabektedin dajali brejim podganam, je prehajal skozi placento.
English: Dehydration Hypokalaemia
Slovenian: Presnovne in prehranske motnje zmanjšanje apetita dehidracija hipokaliemija
English: PHARMACEUTICAL FORM Powder for concentrate for solution for infusion.
Slovenian: FARMACEVTSKA OBLIKA prašek za koncentrat za raztopino za infundiranje bel do belkast prašek
English: What you need to know before you are given Yondelis
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Yondelis Ne uporabljajte zdravila Yondelis:
English: Hepatobiliary disorders
Slovenian: Trombocitopenija:
English: 14C-trabectedin dose at 0.061 mg/kg.
Slovenian: odmerek trabektedina 0,061 mg/kg, označenega s 14C, so opazili prehajanje trabektedina prek placente in fetalno izpostavljenost trabektedinu.
English: Hypotension Flushing
Slovenian: Okvarjeno delovanje jeter
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial label - 0.25 mg vial
Slovenian: Nalepka na viali - 0,25 mg viala
English: as there could be an increased risk of liver or muscle damage.
Slovenian: saj lahko to poveča tveganje hepatotoksičnosti.
English: The safety and efficacy of Ebymect in children and adolescents aged 0 to < 18 years have not yet been established.
Slovenian: Varnost in učinkovitost zdravila Ebymect pri otrocih in mladostnikih v starosti od 0 do < 18 let nista ugotovljeni.
English: Ebymect is contraindicated in patients with:
Slovenian: Zdravilo Ebymect je kontraindicirano pri bolnikih s:
English: • if you drink large amounts of alcohol, either every day or only from time to time (please see section “Ebymect with alcohol”).
Slovenian: • če pijete veliko alkohola (vsak dan ali le od časa do časa) (glejte poglavje "Zdravilo Ebymect skupaj z alkoholom").
English: • acute alcohol intoxication, alcoholism (see section 4.5).
Slovenian: • akutno intoksikacijo z alkoholom, alkoholizmom (glejte poglavje 4.5).
English: More information is given below in ‘Other medicines and Ebymect'.
Slovenian: Več informacij najdete v poglavju "Druga zdravila in zdravilo Ebymect", spodaj.
English: Stop taking Ebymect and see a doctor as soon as possible if you notice any of the following serious or potentially serious side effects:
Slovenian: Nehajte jemati zdravilo Ebymect in čim prej obiščite zdravnika, če opazite katerega od naslednjih resnih ali potencialno resnih neželenih učinkov:
English: Analysis of the results for overweight patients treated with metformin after failure of diet alone showed:
Slovenian: Analiza rezultatov pri pretežkih bolnikih, ki so po neuspehu same diete dobivali metformin, je pokazala:
English: During treatment with Ebymect, your doctor will check your kidney function at least once every year or more frequently if you are elderly and/or if you have worsening kidney function.
Slovenian: Med zdravljenjem z zdravilom Ebymect bo zdravnik vsaj enkrat letno preveril delovanje ledvic, če pa ste starejša oseba in/ali se vam delovanje ledvic slabša, pa še pogosteje.
English: • by modestly increasing insulin sensitivity, improving peripheral glucose uptake and utilisation in muscle;
Slovenian: • z zmernim povečanjem občutljivosti za insulin, s čimer izboljša periferni privzem glukoze in porabo v mišicah,
English: • any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis);
Slovenian: • vse vrste akutne metabolne acidoze (kot sta laktacidoza, diabetična ketoacidoza),
English: • If renal function falls below GFR < 60 mL/min, treatment should be discontinued.
Slovenian: • Če se delovanje ledvic zmanjša pod GFR < 60 ml/min je treba zdravljenje prekiniti.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Ebymect in all subsets of the paediatric population in the treatment of type 2 diabetes (see section 4.2 for information on paediatric use).
Slovenian: Evropska agencija za zdravila je odstopila od zahteve za predložitev rezultatov študij z zdravilom Ebymect za vse podskupine pediatrične populacije za zdravljenje sladkorne bolezni tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: Ebymect should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Slovenian: Zdravila Ebymect se ne sme uporabljati pri bolnikih s sladkorno boleznijo tipa 1 ali za zdravljenje diabetične ketoacidoze.
English: Ebymect must be discontinued at the time of surgery with general, spinal or epidural anaesthesia.
Slovenian: Uporabo zdravila Ebymect je treba v času kirurškega posega pod splošno, spinalno ali epiduralno anestezijo prekiniti.
English: If no adequate strength of Ebymect is available, individual mono-components should be used instead of the fixed dose combination.
Slovenian: Če ustrezne jakosti zdravila Ebymect ni na voljo, je treba razmisliti o uporabi posameznih učinkovin namesto fiksne kombinacije odmerkov.
English: What Ebymect is and what it is used for
Slovenian: Kaj je zdravilo Ebymect in za kaj ga uporabljamo
English: • Before initiation of treatment and regularly thereafter (see sections 4.2, 4.8, 5.1 and 5.2).
Slovenian: • Pred uvedbo zdravljenja in nato redno po njej (glejte poglavja 4.2, 4.8, 5.1 in 5.2).
English: In case of suspected symptoms, the patient should stop taking Ebymect and seek immediate medical attention.
Slovenian: Ob sumu na simptome mora bolnik prenehati z jemanjem zdravila Ebymect in takoj poiskati zdravniško pomoč.
English: Other medicines and Ebymect
Slovenian: Druga zdravila in zdravilo Ebymect
English: If you forget to take Ebymect Do not take a double dose of this medicine to make up for a forgotten dose.
Slovenian: Če ste pozabili vzeti zdravilo Ebymect Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
English: There have been no therapeutic clinical trials conducted with Ebymect tablets.
Slovenian: Terapevtskih kliničnih preskušanj s tabletami zdravila Ebymect niso izvedli.
English: What you need to know before you take Ebymect
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Ebymect
English: You may need more frequent blood glucose and kidney function tests, or your doctor may adjust the dosage of Ebymect.
Slovenian: Morda boste morali pogosteje opravljati preiskave glukoze v krvi in delovanja ledvic, zdravnik pa bo morda moral prilagoditi odmerek zdravila Ebymect.
English: Your doctor may decide to temporarily or permanently stop your treatment with Ebymect.
Slovenian: Zdravnik se bo morda odločil, da vam zdravljenje z zdravilom Ebymect začasno prekine ali trajno konča.
English: Ebymect with alcohol
Slovenian: Zdravilo Ebymect skupaj z alkoholom
English: Ebymect may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly.
Slovenian: Zdravilo Ebymect lahko povzroči zelo redek, a zelo resen neželeni učinek, imenovan laktacidoza, zlasti če ledvice ne delujejo pravilno.
English: Gastrointestinal symptoms i,§
Slovenian: Bolezni prebavil gastrointestinalni simptomi i,§
English: • Lactic acidosis, seen very rarely (may affect up to 1 user in 10,000) Ebymect may cause a very rare, but very serious side effect called lactic acidosis (see section “Warnings and precautions”).
Slovenian: • Laktacidoza, ki se pojavi zelo redko (pojavi se lahko pri največ 1 od 10.000 bolnikov) Zdravilo Ebymect lahko povzroči zelo redek, a zelo resen neželeni učinek, imenovan laktacidoza (glejte poglavje "Opozorila in previdnostni ukrepi").
English: Avoid excessive alcohol intake while taking Ebymect since this may increase the risk of lactic acidosis (see “Warnings and precautions”).
Slovenian: Med jemanjem zdravila Ebymect ne uživajte čezmernih količin alkohola, saj lahko to poveča tveganje za laktacidozo (glejte poglavje "Opozorila in previdnostni ukrepi").
English: • Metformin is contraindicated in patients with GFR of < 30 mL/min and should be temporarily discontinued in the presence of conditions that alter renal function (see section 4.3).
Slovenian: • Metforminom je kontraindiciran pri bolnikih z GFR < 30 ml/min in ga je treba začasno prenehati uporabljati v primeru motenj, ki lahko zmanjšajo delovanje ledvic (glejte poglavje 4.3).
English: Stop taking Ebymect for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal.
Slovenian: Za kratek čas prenehajte jemati zdravilo Ebymect, če imate stanje, ki je lahko povezano z dehidracijo (znatna izguba telesnih tekočin), kot je hudo bruhanje, driska, zvišana telesna temperatura, izpostavljenost vročini ali če pijete manj tekočine, kot običajno.
English: In case of dehydration (severe diarrhoea or vomiting, fever or reduced fluid intake), Ebymect should be temporarily discontinued and contact with a health care professional is recommended.
Slovenian: V primeru dehidracije (huda driska ali bruhanje, zvišana telesna temperatura ali zmanjšan vnos tekočine) je treba jemanje zdravila Ebymect začasno prekiniti; priporoča se posvet z zdravstvenim delavcem.
English: If you need to have an injection of a contrast medium that contains iodine into your bloodstream, for example in the context of an X-ray or scan, you must stop taking Ebymect before or at the time of the injection.
Slovenian: Če vam bodo v krvni obtok injicirali kontrastno sredstvo, ki vsebuje jod, na primer zaradi rentgenskega ali drugega slikanja, morate pred časom injiciranja ali v tem času prenehati z jemanjem zdravila Ebymect.
English: • severe renal failure (GFR < 30 mL/min) (see sections 4.4 and 5.2);
Slovenian: • hudo okvaro ledvic (GFR < 30 ml/min) (glejte poglavji 4.4 in 5.2),
English: The following statements reflect the preclinical safety data of the individual active substances of Ebymect.
Slovenian: Naslednje navedbe temeljijo na predkliničnih podatkih o varnosti za posamezni učinkovini zdravila Ebymect.
English: • acute or chronic disease which may cause tissue hypoxia such as: - cardiac or respiratory failure, - recent myocardial infarction, - shock;
Slovenian: • akutnimi ali kroničnimi boleznimi, ki lahko povzročijo hipoksijo tkiv, kot so npr.: srčno popuščanje ali respiratorna insuficienca, nedaven miokardni infarkt, šok,
English: If you stop taking Ebymect
Slovenian: Če ste prenehali jemati zdravilo Ebymect
English: Combinations not studied Dapagliflozin has not been studied in combination with glucagon-like peptide 1 (GLP-1) analogues.
Slovenian: Dapagliflozin ni raziskan v kombinaciji z analogi glukagonu podobnega peptida 1 (GLP-1).
English: If you need to have major surgery, you must stop taking Ebymect during and for some time after the procedure.
Slovenian: Če morate na večji kirurški poseg, morate v času posega in še nekaj časa po tem prenehati z jemanjem zdravila Ebymect.
English: Ebymect should be given twice daily with meals to reduce the gastrointestinal adverse reactions associated with metformin.
Slovenian: Zdravilo Ebymect je treba uporabljati dvakrat na dan in s hrano, da bi zmanjšali z metforminom povezane neželene učinke na prebavilih.
English: Stop taking Ebymect and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.
Slovenian: Takoj prenehajte jemati zdravilo Ebymect in se obrnite na zdravnika ali najbližjo bolnišnico, če se pojavijo nekateri od simptomov laktacidoze, saj lahko to stanje vodi v komo.
English: Ebymect is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:
Slovenian: Zdravilo Ebymect je indicirano pri odraslih, starih 18 let in več, ki imajo sladkorno bolezen tipa 2, kot dodatek dieti in telesni dejavnosti za izboljšanje urejenosti glikemije:
English: Therefore, this medicinal product is not recommended for use in patients with moderate to severe renal impairment (patients with GFR < 60 mL/min) (see section 4.2).
Slovenian: Zato se uporabe tega zdravila ne priporoča pri bolnikih z zmerno do hudo okvaro ledvic (bolniki z GFR < 60 ml/min) (glejte poglavje 4.2).
English: There are no data from the use of Ebymect or dapagliflozin in pregnant women.
Slovenian: O uporabi zdravila Ebymect ali dapagliflozina pri nosečnicah ni podatkov.
English: Do not take Ebymect
Slovenian: Ne jemljite zdravila Ebymect
English: • hypersensitivity to the active substances or to any of the excipients listed in section 6.1;
Slovenian: • preobčutljivostjo na zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju
English: • if you experience rapid weight loss, feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat, contact a doctor or the nearest hospital straight away.
Slovenian: • če se vam pojavijo hitra izguba telesne mase, slabost ali bruhanje, bolečine v trebuhu, prekomerna žeja, hitro in globoko dihanje, zmedenost, neobičajna zaspanost ali utrujenost, sladek vonj izdihanega zraka, sladek ali kovinski okus v ustih ali spremenjen vonj urina ali znoja; če se pojavi kar koli od tega, se takoj posvetujte z zdravnikom ali pojdite v najbližjo bolnišnico.
English: • acute conditions with the potential to alter renal function such as: - dehydration, - severe infection, - shock;
Slovenian: • akutnimi motnjami, ki lahko spremenijo delovanje ledvic, kot so npr.: dehidracija, huda okužba, šok,
English: No interaction studies have been performed for Ebymect.
Slovenian: Študij medsebojnega delovanja z zdravilom Ebymect niso izvedli.
English: Uncommon (may affect up to 1 in 100 people) • thirst
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov) • žeja
English: What Ebymect looks like and contents of the pack
Slovenian: Izgled zdravila Ebymect in vsebina pakiranja
English: Your doctor will decide when you must stop and when to restart your treatment with Ebymect.
Slovenian: Zdravnik se bo odločil, kdaj morate z jemanjem zdravila Ebymect prenehati in kdaj lahko nadaljujete.
English: If you take more Ebymect tablets than you should, you may experience lactic acidosis.
Slovenian: Če ste vzeli večji odmerek zdravila Ebymect, kot bi smeli Če ste vzeli več tablet zdravila Ebymect, kot bi smeli, se vam lahko pojavi laktacidoza.